SCOPUS 정보 검색 플랫폼

Primary Care Update for Ob/Gyns

Volumn 8, Issue 1, 2001, Pages 25-30

Selective estrogen receptor modulators: The ideal estrogen replacement?

(2) Sexton, Michael J a,b Gherman, Robert B a

a NAVAL MEDICAL CENTER PORTSMOUTH (United States)

b NONE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16 EPIESTROL; CLOMIFENE CITRATE; DROLOXIFENE; ESTRADIOL; ETHAMOXYTRIPHETOL; FARNESDON; FULVESTRANT; IDOXIFENE; MIPROXIFENE PHOSPHATE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN CITRATE; TOREMIFENE; UNCLASSIFIED DRUG;

ARTICLE; BONE MINERAL; BONE PAIN; BREAST CARCINOMA; DEPRESSION; EDEMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HEADACHE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INSOMNIA; ISCHEMIC HEART DISEASE; LEG CRAMP; LIPID METABOLISM; MENSTRUATION DISORDER; MIGRAINE; MYALGIA; NAUSEA; OSTEOPOROSIS; POLYP; POSTMENOPAUSE; PRIORITY JOURNAL; UTERUS CARCINOMA; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINITIS; VARICOSIS; VERTIGO; WEIGHT GAIN;

EID: 0034525572 PISSN: 1068607X EISSN: None Source Type: Journal
DOI: 10.1016/S1068-607X(00)00066-4 Document Type: Article

Times cited : (9)

References (33)

1
- 0026528835
- The normal menopause transition
- (1992) Maturitas , vol.14 , pp. 103-115
- McKinlay, S.M.¹ Brambilla, D.J.² Posner, J.G.³

2
- 0033959520
- Cancer Statistics 2000
- (2000) CA Cancer J Clin , vol.50 , pp. 7-34
- Greene, R.T.¹ Murray, T.² Bolden, S.³ Wingo, P.A.⁴

3
- 0033026861
- Selective estrogen receptor modulators; women's panacea for the next millennium?
- (1999) Am J Obstet Gynecol , vol.180 , pp. 763-770
- Spencer, C.P.¹ Morris, E.P.² Rymer, M.D.³

4
- 0025981467
- Estrogen replacement therapy and coronary heart disease; a quantitative assessment of the epidemiological evidence
- (1991) Prev Med , vol.20 , pp. 47-63
- Stampfer, M.¹ Colditz, G.²

5
- 0029056755
- The use of estrogen and progestin and the risk of breast cancer in postmenopausal women
- (1995) N Engl J Med , vol.332 , pp. 1589-1593
- Colditz, G.A.¹ Haukinson, S.E.² Hunter, D.J.³

6
- 0027761014
- An overview of estrogen replacement therapy in postmenopausal women
- (1993) J Women Health , vol.2 , pp. 289-294
- Scalley, E.K.¹ Henrich, J.B.²

7
- 0030917577
- Controversies surrounding estrogen use in postmenopausal women
- (1997) Ann Pharmacother , vol.31 , pp. 745-755
- Witt, D.M.¹ Lousberg, T.R.²

8
- 0029829442
- Effect of ovarian hormonal therapy on skeletal and extraskeletal tissues in women
- (1996) Can Med Assoc J , vol.155 , pp. 929-934
- Josse, R.G.¹

9
- 0031039888
- Comparison of the ligand binding specificity and transcription tissue distribution of estrogen receptors α and β
- (1997) Endocrinology , vol.138 , pp. 863-870
- Kuiper, G.G.¹ Carlsson, B.² Grandien, K.³

10
- 0030995945
- Estrogen receptor ligands modulate its interaction with DNA
- (1997) J Biol Chem , vol.272 , pp. 11384-11391
- Cheskis, B.J.¹ Karathanasis, S.² Lyttle, C.R.³

11
- 0032537990
- Tamoxifen for prevention of breast cancer; report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
- (1998) J Natl Cancer Inst , vol.90 , pp. 1371-1388
- Fisher, B.¹ Constatine, J.P.² Wickerham, D.L.³

12
- 0033575083
- The effect of raloxifene on risk of breast cancer in postmenopausal women; results from the MORE randomized trial
- (1999) JAMA , vol.281 , pp. 2189-2197
- Cumming, S.R.¹ Eckert, S.² Krueger, K.A.³

13
- 0006543607
- Jordan VC, Glusman J, Eckert S, et al. Incident primary breast cancer are reduced by raloxifene: integrated data from multicenter, double-blind, randomized trials in 12,000 postmenopausal women (abstract). In: American Society of Clinical Oncologists, 34th Annual Meeting, 1998:446.

14
- 0028033883
- Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years
- (1994) Arch Intern Med , vol.154 , pp. 2585-2588
- Lowe, R.¹ Barden, H.² Mazess, R.³ Epstein, S.⁴ Chapell, R.⁵

15
- 0024381108
- Effects of tamoxifen on spinal bone density in women with breast cancer
- (1989) J Natl Cancer Inst , vol.81 , pp. 1086-1088
- Turken, S.¹ Siris, E.² Seldin, D.³ Flaster, E.⁴ Hyman, G.⁵ Lindsay, R.⁶

16
- 0030070093
- Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women
- (1996) J Clin Oncol , vol.14 , pp. 78-84
- Powles Tm Hickish, T.¹ Kanis, J.² Tidy, A.³ Ashley, S.⁴

17
- 0026585852
- Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
- (1992) N Engl J Med , vol.326 , pp. 852-856
- Love, R.R.¹ Mazess, R.B.² Baren, H.S.³

18
- 0033581212
- Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene; results from a 3-year randomized clinical trial
- (1999) JAMA , vol.282 , pp. 637-645
- Ettinger, B.¹ Black, D.M.² Mitlak, B.H.³

19
- 0030664688
- Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
- (1997) N Engl J Med , vol.337 , pp. 1641-1647
- Delmas, P.D.¹ Bjarnson, N.H.² Mitlak, B.H.³

20
- 0030941737
- Coronary heart disease mortality and adjuvant tamoxifen therapy
- (1997) J Natl Cancer Inst , vol.89 , pp. 776-782
- Costantino, J.P.¹ Kuller, L.H.² Ives, D.G.³

21
- 0030015080
- A controlled trial of raloxifene (LY 139481) HCL; impact on bone turnover and serum lipid profile in healthy postmenopausal women
- (1996) J Bone Miner Res , vol.11 , pp. 835-842
- Draper, M.W.¹ Flowers, D.E.² Huster, W.J.³ Neild, J.A.⁴ Harper, K.D.⁵ Arnaud, C.⁶

22
- 2642712522
- Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
- (1998) JAMA , vol.279 , pp. 1445-1471
- Walsh, B.W.¹ Kuller, L.H.² Wild, R.A.³

23
- 0025364851
- Hysteroscopic follow-up during tamoxifen treatment
- (1990) Eur J Obstet Reprod Biol , vol.35 , pp. 235-238
- Neven, P.¹ De Muylder, X.² Van Belle, Y.³ Vanderick, G.⁴ De Muylder, E.⁵

24
- 34347367431
- American College of Obstetricians and Gynecologists Committee Opinion; tamoxifen and endometrial cancer
- (1996) Int J Gynecol Obstet , vol.53 , pp. 197-199

25
- 0028208456
- Endometrial cancer in tamoxifen-treated breast cancer patients; findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
- (1994) J Natl Cancer Inst , vol.86 , pp. 527-537
- Fisher, B.¹ Constantino, J.P.² Redmond, C.K.³

26
- 0002258194
- Raloxifene reduces the risk of breast cancer and may decrease the risk of endometrial cancer in postmenopausal women. Two year findings from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial
- (abstract)
- (1998) Proc Am Soc Clin Oncol , vol.17 , pp. 2
- Cummings, S.R.¹ Norton, I.² Eckert, S.³

27
- 0033989921
- A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium
- (2000) Obstet Gynecol , vol.95 , pp. 95-103
- Goldstein, S.R.¹ Scheele, W.H.² Rajagopalan, S.K.³ Wilkie, J.L.⁴ Walsh, B.W.⁵ Parsons, A.K.⁶

28
- 0031790699
- Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles
- (1998) J Clin Endocrinol Metab , vol.83 , pp. 6-13
- Baker, V.L.¹ Draper, M.² Paul, S.³

29
- 0029952875
- Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators
- (1996) Mol Carcinog , vol.17 , pp. 151-159
- Fuchs-Young, R.¹ Howe, S.² Hale, L.³ Miles, R.⁴ Walker, C.⁵

30
- 0006516642
- Nolvadex; tamoxifen citrate, Wilmington, DE: Zeneca Pharmaceuticals
- (1998)

31
- 0033013227
- Adverse events reported by postmenopausal women in controlled trials with raloxifene
- (1999) Obstet Gynecol , vol.93 , pp. 558-565
- Davies, G.C.¹ Huster, W.J.² Lu, Y.³

32
- 0030591669
- Effect of oestrogen during menopause on risk and age of onset of Alzheimer's disease
- (1996) Lancet , vol.348 , pp. 429-432
- Tang, M.X.¹ Jacobs, D.² Stern, Y.³

33
- 0032416079
- Selective estrogen receptor modulators; a new category of therapeutic agents for extending the health of postmenopausal women
- (1998) Am J Obstet Gynecol , vol.179 , pp. 1479-1484
- Goldstein, S.R.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.